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Functional Heterogeneity of Human CD34" Cells Isolated in
Subcompartments of the G0 /G1 Phase of the Cell Cycle
By Andre´ Gothot, Robert Pyatt, Jon McMahel, Susan Rice, and Edward F. Srour
Using simultaneous Hoechst 33342 (Hst) and Pyronin Y (PY) hematopoiesis was maintained for up to 6 weeks with
staining for determination of DNA and RNA content, respec- G0CD34" cells, whereas production of clonogenic progeni-
tively, human CD34" cells were isolated in subcompart- tors was more limited in cultures initiated with G1CD34"
ments of the G0/G1 phase of the cell cycle by flow cytometric cells. To test the hypothesis that primitive LTHC-ICs would
cell sorting. In both bone marrow (BM) and mobilized periph- reenter a state of relative quiescence after in vitro division,
eral blood (MPB) CD34" cells, primitive long-term hemato- BM CD34" cells proliferating in ex vivo cultures were identi-
poietic culture-initiating cell (LTHC-IC) activity was higher in fied from their quiescent counterparts by a relative loss of
CD34" cells isolated in G0 (G0CD34" cells) than in those resid- membrane intercalating dye PKH2, and were further frac-
ing in G1 (G1CD34" cells). However, as MPB CD34" cells dis- tionated with Hst and PY. The same functional hierarchy
played a more homogeneous cell-cycle status within the G0/ was documented within the PKH2dim population whereby
G1 phase and a relative absence of cells in late G1, DNA/ LTHC-IC frequency was higher for CD34" cells reselected in
RNA fractionation was less effective in segregating LTHC- G0 after in vitro division than for CD34" cells reisolated inIC in MPB than in BM. BM CD34" cells belonging to four G1 or in S/G2 " M. However, the highest LTHC-IC frequencysubcompartments of increasing RNA content within the G0/ was found in quiescent PKH2bright CD34" cells. Together,
G1 phase were evaluated in functional assays. The persis- these results support the concept that cells with distincttence of CD34 expression in suspension culture was in-
hematopoietic capabilities follow different pathways duringversely correlated with the initial RNA content of test cells.
the G0/G1 phase of the cell cycle both in vivo and during exMultipotential progenitors were present in G0 or early G1
vivo culture.subcompartments, while lineage-restricted granulomono-
q 1997 by The American Society of Hematology.cytic progenitors were more abundant in late G1. In vitro
T cells from those in G1 that may represent cell populationsHE CELL-CYCLE STATUS and responsiveness to invitro cytokine stimulation is critical in defining strate- with distinct hematopoietic capabilities. Although the suicide
gies for hematopoietic progenitor/stem cell expansion1-3 and techniques using 3H-thymidine16-18 or cytosine arabinoside19
somatic gene therapy.4,5 It is generally believed that primitive are dynamic procedures capable of determining the relative
hematopoietic progenitor cells (HPCs) lie dormant within proportion of resting versus cycling HPCs, they rely on se-
the bone marrow (BM) microenvironment.6-8 Supporting this lective killing of actively cycling cells, therefore preventing
hypothesis is evidence that primitive HPCs, unlike commit- their functional characterization. This prompted us to evalu-
ted progenitors, display a latency period before they respond ate the use of multiparameter flow cytometry methods appli-
to cytokine-driven cell-cycle activation9-11 and that they are cable to viable CD34/ cells and potentially capable of dis-
resistant to exposure to antimitotic drugs like 5-fluoroura- criminating between subcompartments of the G0/G1 phase
cil.12-14 Cell-cycle analysis and sorting by direct measure- of the cell cycle.
ment of DNA content with Hoechst 33342 (Hst) has been The ability to correlate the DNA content of individual
used to compare the hematopoietic function of cells in G0/ cells to other cell constituents such as total RNA or proteins
G1 versus those in S/G2/M phases.15 However, such a static has led to the description of different kinetic compartments
‘‘snapshot’’ measurement does not distinguish quiescent G0 within the traditional phases of the cell cycle. In particular,
subcompartments of the G0/G1 phase were described based
on simultaneous DNA/RNA determination.20-23 Cells with
low RNA content maintain a state of deep dormancy in G0.From the Division of Hematology/Oncology and Indiana Elks
As cells enter G1, they accumulate RNA, mainly in the formCancer Research Center, the Department of Medicine, and the De-
partment of Pediatrics, Herman B Wells Center for Pediatric Re- of ribosomal RNA, until they reach S phase. In a variety of
search, Indiana University School of Medicine, Indianapolis. cell systems, the rate of progression of individual cells
Submitted May 16, 1997; accepted July 30, 1997. through the cell cycle was found to be correlated with RNA
Supported by National Institutes of Health Grant No. R01- content.24 Although Lajtha25 originally coined the term G0HL55716, National Institutes of Health Centers of Excellence in to describe dormant hepatic cells responding to liver insult,Molecular Hematology Grant No. P50-DK49218, National Institutes
other cell types residing in quiescent mitotic state character-
of Health Grant No. P01-HL53586, a research award from the Phi
ized by a lower RNA content than G1 cells have been referredBeta Psi Sorority (E.F.S.), a fellowship from the Fonds National de
to as G1Q or G0 cells.22 In a recent study from our laboratory,la Recherche Scientifique (FNRS, Brussels, Belgium; A.G.), and a
simultaneous DNA/RNA staining of BM CD34/ cells wastravel grant from the Centre Anticance´reux pre`s l’ULg (University
of Lie`ge, Belgium; A.G.). used successfully to isolate, by flow cytometry, quiescent
Address reprint requests to Edward F. Srour, PhD, Indiana Uni- and primitive HPCs in the G0 phase of the cell cycle.26 The
versity School of Medicine, 1044 W Walnut St, R4-202, Indianapolis, possibility to isolate viable HPCs with distinct DNA/RNA
IN 46202-5121. content was used for the present study to compare hemato-
The publication costs of this article were defrayed in part by page poietic function of CD34/ cells isolated in subcompartments
charge payment. This article must therefore be hereby marked
of the cell cycle.
‘‘advertisement’’ in accordance with 18 U.S.C. section 1734 solely to
We have previously shown10 that cytokine nonresponsiveindicate this fact.
(CNR) cells, which resist initial cytokine stimulation andq 1997 by The American Society of Hematology.
0006-4971/97/9011-0009$3.00/0 survive in culture for up to 7 days, are enriched for primitive
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these experiments were initially sorted with APC-conjugated anti-HPCs, while those undergoing in vitro proliferation appear
CD34 (Caltag) followed by Hst/PY fractionation. Cells were platedto gradually lose their hematopoietic potential.27 We hypoth-
in culture medium consisting of IMDM, 10% FCS, 2 mmol/L L-esized that if proliferating cells were to maintain primitive
glutamine, and antibiotics, referred to hereafter as complete medium,function, they would reenter after cell division into a quies-
supplemented with interleukin-3, (IL-3), IL-6, and stem cell factor
cent state characterized by minimal RNA content. Experi- (SCF) at 100 ng/mL each. After 24 to 144 hours in culture, cells
ments were performed to investigate whether primitive HPCs
were harvested and subjected to high-resolution cell-cycle analysis
could be reisolated from ex vivo expansion cultures by cell- as recently described by Jordan et al,28,29 with minor modification.
cycle fractionation. Cells were washed and resuspended in 1 mL phosphate-buffered
In the present studies, we assayed the hematopoietic func- saline (PBS) / 0.4% formaldehyde. After 30 minutes at 47C, 1 mL
PBS / 0.2% Triton X-100 was added, and the cells were left over-tion of CD34/ cells isolated from distinct subcompartments
night at 47C. The cells were then washed twice in PBS / 1% bovineof the G0/G1 phase of the cell cycle by DNA/RNA staining.
serum albumin (BSA) and stained with FITC-conjugated anti–Ki-Such CD34/ cell subsets were evaluated in steady-state BM,
67 (clone MIB-1; Immunotech, Westbrook, ME) for 60 minutes atin mobilized peripheral blood (MPB), and in the context
47C. Isotype controls were stained in parallel. Finally, cells wereof ex vivo expansion. Our results demonstrate that major
washed and resuspended in PBS / 1% BSA containing 5 mg/mLfunctional differences could be attributed to the position of 7-aminoactinomycin-D ([7-AAD] Sigma). After a 3-hour incubation
these cells in the G0/G1 phase, and suggest that primitive on ice, samples were run on a FACScan flow cytometer (BDIS)
and committed progenitor cells follow different pathways in using FL-1 and FL-3 channels for Ki-67 and 7-AAD, respectively.
the G0/G1 phase of the cell cycle. Alternatively, conventional cell-cycle analysis by DNA staining with
propidium iodide was used as previously described.3
MATERIALS AND METHODS Long-term culture of CD34/ subpopulations and progenitor
assays. CD34/ cells isolated in G0/G1 subcompartments wereCD34/ cell purification. BM and MPB samples were obtained
seeded in 24-well plates at a density of 104 cells/mL in completefrom healthy adult volunteers according to guidelines established by
medium supplemented with IL-3, IL-6, and SCF, each at 100 ng/the Human Investigation Committee of the Indiana University
mL. Every week, half of the cells were removed, followed by re-School of Medicine. Mobilization was achieved by daily G-CSF
placement with fresh medium and cytokines. Aliquots of harvestedadministration at 5 mg/kg (maximum, 480 mg/d) for 4 consecutive
cells were assayed for progenitor cell content in 1.3% methylcellu-days. MPB cells were collected by apheresis on day 5. Low-density
lose, 30% FCS, 100 ng/mL SCF, 10 ng/mL IL-3, 10 ng/mL IL-6, 5mononuclear cells from both tissues were isolated by centrifugation
ng/mL GM-CSF, and 2 U/mL erythropoietin (EPO). Hematopoieticover Ficoll-Paque (Pharmacia Fine Chemicals, Piscataway, NJ) and
colonies were scored 2 weeks later according to standard criteria.were enriched for CD34/ cells by immunomagnetic selection as
Persistence of CD34 expression in culture. After 2 weeks ofpreviously described.10 All reagents for the immunomagnetic separa-
long-term culture, aliquots of cultured cells were harvested, washed,tion procedure were a generous gift from Baxter Healthcare (Santa
and resuspended in 100 mL mouse serum (Sigma). After a 10-minuteAna, CA). Immunomagnetically selected CD34/ cells were labeled
incubation at room temperature, FITC-conjugated anti-CD34 anti-with fluorescein isothiocyanate (FITC)-conjugated anti-CD34 anti-
body or an isotype-matched control (BDIS) were added to the cellbody (Becton Dickinson Immunocytometry Systems [BDIS], San
suspension. Staining was performed for 20 minutes on ice, afterJose, CA) or in some cases with allophycocyanin (APC)-conjugated
which cells were washed and analyzed on a FACScan flow cytom-anti-CD34 (Caltag, San Francisco, CA) to allow for further staining
eter. CD34 expression was measured only on cells with low forward-with FITC-conjugated anti–Ki-67 antibody. Total BM or MPB
and side-scatter properties, and was defined as cells displaying aCD34/ cells were isolated on a FACStar Plus flow cytometer
fluorescence greater than 99% of the isotype control.(BDIS). For some of the MPB samples in which CD34/ cell purity
Analysis of ex vivo expansion with PKH2 cell tracking and cell-was greater than 90% after immunomagnetic selection, the flow
cycle fractionation. A total of 0.5 to 1 1 106 CD34/ cells werecytometry purification step was omitted.
labeled with the membrane dye PKH2 (Sigma) for cell tracking perCell-cycle fractionation with Hst and Pyronin Y. Total CD34/
the manufacturer’s instructions. Although PKH26 (emission at 575cells were resuspended at 1 to 2 1 106 cells in 1.5 mL 1.67-mmol/
nm) has been reported to be a more reliable indicator of cell prolifer-L solution of Hst (Molecular Probes, Eugene, OR) in Hst buffer.
ation, PKH2 (emission at 530 nm) was used in this study to allowHst buffer consisted of Hanks’ balanced salt solution (Biowhittaker,
simultaneous use with PY. After staining, cells were counted andWalkersville, MD), 20 mmol/L HEPES (Biowhittaker), 1 g/L glu-
plated in 24-well plates at a density of 2 1 105 cells/mL in completecose, and 10% fetal calf serum ([FCS] Hyclone, Logan, UT). After
medium supplemented with IL-3, IL-6, and SCF, all at 100 ng/mL.incubation at 377C for 45 minutes, Pyronin Y ([PY] Sigma, St Louis,
An aliquot of PKH2-stained cells was fixed in 1% paraformaldehydeMO) prepared in Hst buffer was added at a final concentration of 1
and kept at 47C for determination of day 0 PKH2 fluorescence.mg/mL and the cells were further incubated for another 45 minutes
Cultures were fed with cytokines every 48 hours. Care was takenat 377C. The cells were washed once, resuspended in Hst buffer,
to avoid cell densities higher than 5 1 105 cells/mL by frequentand sorted on a FACStar Plus equipped with an argon laser providing
splitting of the cultures to minimize dye transfer between cells. Afterthe 488-nm excitation for PY and a krypton laser providing the 350-
7 days, subpopulations of CD34/ cells were sorted in two steps asnm excitation for Hst. The PY signal was selected with a 575 { 13
follows.nm band-pass filter, and Hst was detected with a 424 { 22 nm band-
Cultured cells were counted, washed, and stained with biotinylatedpass filter. Sorting windows were constructed as depicted in Fig 1A.
anti-CD34 monoclonal antibody (Caltag) followed by streptavidinSince, by definition, RNA staining with PY yields a continuous
(SA)-APC (Molecular Probes). Controls consisted of biotinylatedhistogram without demarcation between positive and negative cells,
isotype-matched control IgG followed by SA-APC. Cells werean arbitrary sorting window comprising 10% to 15% of cells dis-
washed and resuspended in PBS / 1% BSA and sorted into twoplaying minimal PY staining and 2n DNA content was used to sort
groups. The first consisted of CD34/PKH2bright cells, designatingG0CD34/ cells in all experiments (Fig 1A). Viability and purity of
those that had not divided in culture, and the second containedsorted cells always exceeded 98% and 90%, respectively.
Short-term culture and cell-cycle analysis. CD34/ cells used in CD34/PKH2dim cells, representing those that had divided and there-
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Fig 1. General method of cell-cycle fractionation
using DNA and RNA analysis with Hst and PY. (A)
Dual-parameter dot plot showing analysis of BM
CD34" cells stained with Hst and PY. Cells residing
in G0 (low PY uptake) appear at the bottom of the
G0/G1 region identified by low Hst staining. Cells in
G1 have a brighter PY signal within the G0/G1 peak.
Cells in S/G2 " M display both high Hst and high
PY staining. (B) Postsort analysis of BM CD34" cells
sorted in G0. (C) Hst/PY fluorescence distribution of
G0 CD34" cells shown in B after 24 hours under IL-3-
IL-6-SCF stimulation, showing G0-G1 progression. (D)
Same sample after 72 hours in culture, depicting
cells moving into S/G2 " M phase.
fore lost part of their original PKH2 fluorescence. Sorted cellular RNA content by staining with PY. Quiescent cells,
CD34/PKH2dim cells were further stained with Hst and PY as already in G0, have a low RNA content.22 As cells progress through
described, and were sorted in a second step into cells residing in G1, they accumulate RNA and finally move to the S/G2 /
G0, G1, or S/G2 / M. M phase during which Hst staining increases (Fig 1).
Limiting dilution analysis of long-term hematopoietic culture-ini- To assess the validity of Hst/PY cell-cycle fractionation,
tiating cells. LTHC-IC frequencies were determined by a stroma-
we compared it with a recently described method of high-free limiting dilution analysis as described previously.10 LTHC-IC
resolution cell-cycle analysis, ie, the Ki-67/7-AADfrequencies were calculated using Poisson statistics.30
method.28,29 In this procedure, a DNA histogram is generatedGrowth factors. Human recombinant IL-3, IL-6, SCF, and GM-
by 7-AAD and plotted against expression of the nuclearCSF were a kind gift from Amgen (Thousand Oaks, CA). Human
antigen Ki-67, which is present in cycling cells but not inrecombinant EPO was obtained from Amgen.
G0 cells.31 Consecutive measurements of Hst/PY and Ki-67/Statistics. Comparisons of cell populations isolated in various
phases of the cell cycle were made by analysis of variance (AN- 7-AAD were performed. MPB CD34/ cells were sorted in
OVA). If P (ANOVA) was less than .05, pairwise multiple compari- either G0 or G1 as defined by Hst/PY staining, plated in
sons were made using Student-Newman-Keuls (SNK) tests. When short-term cultures, and analyzed at different time intervals
only two groups were to be compared, Student’s t-tests were used. with Ki-67/7-AAD (Fig 2). Most of the cells (87% in the
All P values are two-sided. SigmaStat 2.0 software (Jandel, San example shown in Fig 2) recovered from cultures initiated
Rafael, CA) was used for all calculations. with G0CD34/ cells were Ki-67–negative 24 hours after
initiation. Expression of Ki-67 was progressively upregu-
RESULTS lated while cells entered G1 and S/G2 / M stages at 72 and
Fractionation of CD34/ cells into subcompartments of the 144 hours, but a significant percentage of cells, 14.3%, were
G0/G1 phase of the cell cycle. Traditional cell-cycle analy- still Ki-67–negative after 144 hours in culture. In G1CD34/
sis with a DNA probe such as Hst distinguishes between cell–initiated cultures, the vast majority of cells entered into
cells in the S/G2 / M phase and those in the G0/G1 phase. active phases of the cell cycle immediately after cytokine
We have recently described the successful isolation of stimulation and were Ki-67–positive (93%) at 24 hours
CD34/ cells in the G0 phase of the cell cycle by simultaneous after initiation of short-term culture. Interestingly, whereas
DNA/RNA staining.26 In this method, cells determined to be only 3% of G0CD34/ cells traversed into active phases of
in the G0/G1 phase based on Hst fluorescence distribution the cell cycle 24 hours after exposure to cytokines, almost
50% of initial G1CD34/ cells were detected in S/G2 / M atcan be further fractionated into subcompartments of varying
AID Blood 0007 / 5h43$$$122 10-28-97 18:47:38 blda WBS: Blood
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Fig 2. Serial high-resolution cell-cycle analysis of cytokine-stimulated G0 and G1 CD34" cells. MPB G0 and G1 CD34" cells were plated in
complete medium supplemented with IL-3-IL-6-SCF. At indicated times, cells were harvested and analyzed for cell-cycle status with 7-AAD
and Ki-67. (A) Dual-parameter plot showing fractionation of CD34" cells in G0 and G1 phases with Hst and PY. (B to D) Cell-cycle analysis of
cells harvested from G1 CD34" cell–initiated culture at 24, 72, and 144 hours, respectively. (E to G) Cell-cycle analysis of cells harvested from
G0CD34" cell–initiated culture at 24, 72, and 144 hours, respectively. The percentage of cells in G0, G1, and S/G2 " M (abbreviated as G2) is
indicated. Cells in the lower right quadrant were not considered.
the same time point. A similar delayed expression of Ki-67 A statistical difference was observed between the LTHC-IC
frequency of G0CD34/ cells and G1CD34/ cells for bothand late onset of DNA synthesis in cultures initiated with
G0CD34/ cells compared with cultures initiated with tissues. However, although a ninefold difference in the fre-
quency of LTHC-IC between G0CD34/ cells and G1CD34/G1CD34/ cells was observed for BM CD34/ cells (data not
shown). These results demonstrate that CD34/ cell subsets cells was documented for BM (P  .009), only a twofold
difference (P  .02) was demonstrated for the same twopossessing different rates of cell-cycle activation by cyto-
kines were identified and isolated by Hst/PY staining. fractions of MPB cells, indicating that increased homogene-
ity in the cell-cycle status of MPB CD34/ cells versus BMAssessment of LTHC-IC activity after cell-cycle fraction-
ation of BM and MPB CD34/ cells. The ability of Hst/ CD34/ cells was associated with a more pronounced func-
PY staining to achieve fractionation of primitive HPCs was
compared for BM and MPB. Reports from several groups18,32
and from our laboratory33 indicated that MPB CD34/ cells
consist of a population of noncycling cells, as compared with
BM CD34/ cells. These observations were confirmed in the
present study by standard propidium iodide DNA staining,
such that 13.0% { 2.0% of freshly isolated BM CD34/ cells
were in S/G2 / M phase versus 0.81% { 0.66% for MPB
CD34/ cells (P  .0001). We extended these previous find-
ings by examining the relative abundance of PYlow (G0) and
PYbright (G1) cells within the G0/G1 peak in both tissues.
Representative dot plots in Fig 1A (BM) and Fig 2A (MPB)
show that MPB CD34/ cells are enriched for cells displaying
low RNA staining within the G0/G1 phase, suggesting that
relative to BM CD34/ cells, MPB CD34/ cells are not only
devoid of cells in S/G2 / M but also cells in late G1 phase.
To compare the efficiency of Hst/PY staining to separate
primitive HPCs in BM and MPB, G0 and G1 CD34/ cells
Fig 3. LTHC-IC frequencies of G0 and G1 CD34" cells isolated fromwere sorted from both sources and assayed for LTHC-IC
BM and MPB. Frequencies are given per 100 cells as the mean Ô
activity (Fig 3). For these experiments, G0 and G1 CD34/ SEM, n ! 8 BM and 7 MPB. Samples were compared with t tests. *P
cells were defined for both tissues as having minimal and ! .009 v BM G1CD34" cells; **P ! .02 v MPB G1CD34" cells; ***P !
.01 v BM G1CD34" cells.maximal PY staining within the G0/G1 peak, respectively.
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limiting dilution analysis assay as previously described (Fig
5B). LTHC-IC frequencies were inversely correlated with
the initial RNA content of test cells. The highest LTHC-IC
content was found in the G0CD34/ cell subset. G1aCD34/
cells had 50% less LTHC-IC than G0CD34/ cells (P  .05),
while CD34/ cells isolated in late G1 phases, G1b and G1c
CD34/ cells, had low or nearly undetectable LTHC-IC fre-
quencies (P  .05 v G0CD34/ cells). Altogether, these re-
sults indicate that in steady-state hematopoiesis, functionally
distinct populations of HPCs can be identified along the G0/
G1 pathway of the cell cycle. Multipotential CFU and CFU
precursors reside in G0 and to a lesser degree in early G1
phase, while late G1 subcompartments appear to contain
mainly committed progenitors.
We next determined the ability of G0/G1 subcompartments
of BM CD34/ cells to maintain in vitro hematopoiesis in
long-term cultures. CD34/ cells isolated with varying RNA
content within the G0/G1 phase (Fig 4) were plated in stroma-Fig 4. Fractionation of steady-state BM CD34" cells into 4 G0/G1
subcompartments using DNA/RNA analysis with Hst and PY. Sorting free suspension cultures and stimulated by a combination of
gates defining four subcompartments of G0/G1 phase are indicated. IL-3, IL-6, and SCF. At weekly intervals, aliquots of cells
were replated in progenitor cell assays to determine CFU
production (Fig 6). CFUs were detectable up to 6 weeks in
cultures initiated with both G0CD34/ cells and G1aCD34/tional homogeneity. In addition, G1CD34/ cells isolated
cells, while CFU production was exhausted after 2 weeks infrom BM had a lower LTHC-IC frequency (0.7% { 0.2%)
cultures of CD34/ subsets isolated in G1b or G1c . Total CFUthan their counterparts isolated from MPB (5.7% { 2.0%,
output was maximal in G0CD34/ cell–initiated cultures, andP  .01), whereas no statistical difference was observed
decreased in other cell subsets in inverse relationship to thebetween G0CD34/ cells isolated from these two sources (P
initial RNA content of the test cells (Fig 6). The persistence .17). This suggests that a specific subpopulation of CD34/
of CD34 expression among cultured cells was monitored oncells residing in late G1 in the BM microenvironment, and
day 14 in similar long-term cultures (Table 1). The percent-whose primitive HPC function is largely compromised, is
age of CD34/ cells in vitro correlated with CFU productionnot recovered after mobilization into the PB.
Hematopoietic function of BM CD34/ cells isolated in
subcompartments of the G0/G1 phase of the cell cycle. Addi-
tional experiments were performed to examine in more detail
the functional heterogeneity of BM CD34/ cells as a function
of their position within the prereplicating phase of the cell
cycle. Using Hst/PY staining, we arbitrarily defined four
subcompartments of increasing RNA content in the G0/G1
phase of the cell cycle, termed hereafter G0, G1a , G1b , and
G1c (Fig 4). Sorting windows for G1a , G1b , and G1c were
constructed to contain the same percentage of cells as con-
tained in the sorting window for G0 cells defined as depicted
in Fig 1A. BM CD34/ cells isolated in these subcompart-
ments were used for subsequent functional assays.
The relative contribution of each of the CD34/ cell subsets
to late and primitive progenitor populations was assessed by
colony-forming unit (CFU) and LTHC-IC assays, respec-
tively. Overall CFU frequency was not significantly different
between cell subsets, and was 15.2% { 3.4% in G0CD34/
cells, 18.3% { 5.8% in G1aCD34/ cells, 17.4% { 3.8% in
Fig 5. Functional characterization of steady-state BM CD34" cellsG1bCD34/ cells, and 8.3% { 3.8% in G1cCD34/ cells (n 
isolated in subcompartments of G0/G1 phase. (A) Progenitor cell3, P  .05). However, different types of progenitors were
assay. The number of hematopoietic colonies are given per 100 cellsdetected in these cell populations such that G0CD34/ cells plated. Data shown above are the mean Ô SEM of three experiments
had a significantly higher frequency (P .05) of multipoten- performed in duplicate. BFU-E, burst-forming unit–erythroid; CFU-
GM, colony-forming unit–granulocyte/macrophage; CFU-MIX, CFU-tial progenitors (CFU-MIX) than G1a , G1b , and G1c CD34/
mixed. *P Ú .05 v G1a, G1b, and G1c CD34" cells; **P Ú .05 v G1a andcell populations (Fig 5A), but a significantly lower frequency
G1b CD34" cells. (B) LTHC-IC assay. Frequencies are given per 100(P  .05) of myeloid committed progenitors (CFU-GM) cells as the mean Ô SEM, n ! 4. ***PÚ .05 v G1b and G1c CD34" cells.
than G1a and G1b CD34/ cells. Statistical analysis was made by ANOVA followed by SNK pairwise
comparisons.LTHC-IC frequencies were measured in our stroma-free
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Fig 6. Time course of CFU production in long-term cultures initi-
ated with BM CD34" cells isolated in subcompartments of G0/G1
phase. Data are from one representative experiment of a total of
three. Cells with indicated phenotype were cultured for 7 weeks in
complete medium supplemented with IL-3-IL-6-SCF. Every week,
CFUs were enumerated in HPC assays. The number of CFUs (Ì103)
per 104 initial cells plated are shown above for each time point.
and was highest in cultures initiated with CD34/ cells dis-
Fig 7. Sequential sorting of ex vivo–expanded CD34" cells by cellplaying low RNA content (P  .05). It is interesting that tracking with PKH2 and cell-cycle fractionation with Hst and PY. Fresh
after 2 weeks in LTC, the absolute number of CD34/ cells sorted CD34" cells were stained with PKH2 on day 0 (A). Cells were
then cultured for 7 days in complete medium supplemented with IL-had expanded threefold in cultures initiated with G0CD34/
3-IL-6-SCF (100 ng/mL each). On day 7, harvested cells were stainedcells, while it had remained stable in G1aCD34/ cells and
with CD34-Biotin/streptavidin-APC and analyzed with PKH2 (B).decreased approximately 80% and 88% in G1bCD34/ and Placement of the vertical cursor was adjusted with reference to day 0
G1cCD34/ cell–initiated cultures, respectively. PKH2, and the horizontal cursor with reference to the isotype control.
Maintenance of hematopoietic function in ex vivo–ex- Sorting windows including CD34"PKH2bright and CD34"PKH2dim are
indicated. In the second step, sorted CD34"PKH2dim cells were stainedpanded BM CD34/ cells isolated in different phases of the
with Hst and PY and were further fractionated by DNA/RNA analysiscell cycle. In a subsequent step, we reasoned that upon
into G0, G1, and S/G2 " M phases of the cell cycle (C).
completion of cell division, the most primitive progenitors
may reenter transiently into a state of quiescence while more
committed progenitors remain mitotically active. Previous
already pointed out that a significant proportion of LTHC-
studies from our laboratory using PKH2 cell tracking10 had
ICs contained in ex vivo expansion cultures belonged to a
group of quiescent cells surviving in the absence of cell
division, termed CNR cells. To distinguish nondividing
Table 1. Persistence of CD34 Expression in Cultures Initiated With LTHC-ICs from those reentering G0 after in vitro prolifera-
BM CD34" Cells Isolated in Subcompartments of the G0/G1 tion, we combined PKH2 cell tracking with DNA/RNA frac-
Phase of the Cell Cycle tionation (Fig 7). Following ex vivo expansion for 7 days,
Cultures Initiated on % CD34/ Cells Total No. of CD34/ CD34/ cells were first separated into PKH2bright and PKH2dim
Day 0 With on Day 14 Cells on Day 14‡
subsets as quiescent and proliferating cells, respectively (Fig
G0CD34/ 7.83 { 0.85* 29,383 { 14,756 7A and B). PKH2dim cells were further fractionated by Hst/
G1aCD34/ 4.31 { 0.39† 10,667 { 2,462 PY staining (Fig 7C) into three subpopulations, namely G0,
G1bCD34/ 1.21 { 0.57 6,167 { 1,999 G1, and S/G2 / M. All cell populations were assayed for
G1cCD34/ 0.53 { 0.23 1,869 { 1,255 LTHC-IC content.
A total of 104 BM CD34/ cells isolated from G0/G1 subcompartments In accordance with our previous studies,10,33 the total num-
(Fig 4) were plated in complete medium supplemented with IL-3-IL- ber of LTHC-ICs (Table 2) slightly decreased over a 7-day
6-SCF. After 14 days, the persistence of CD34 expression was deter- period in suspension cultures supported with IL-3, IL-6, and
mined by FACS analysis of cultured cells. Data are the mean { SEM, SCF. Analysis of PKH2 fluorescence showed that approxi-
n  3. Statistical analysis was by ANOVA followed by SNK pairwise
mately 30% of total LTHC-ICs recovered from ex vivo cul-comparisons.
tures did not respond to the cytokine stimulation used in* P  .05 v cultures initiated with G1a, G1b, and G1c CD34/ cells.
these studies, and were still in the CD34/PKH2bright subset† P  .05 v cultures initiated with G1b and G1c CD34/ cells.
after 7 days in ex vivo expansion cultures.‡ Total number of CD34/ cells calculated by multiplying the percent-
age of CD34/ cells by the total cell number present in each culture. Within the CD34/PKH2dim cell population (Fig 8), cells
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Table 3. Proliferation Rate of G0CD34" Cells IsolatedTable 2. Absolute Number of LTHC-ICs Detected Among Freshly
Isolated and Ex Vivo–Expanded CD34" Cells Before and After Ex Vivo Expansion
% Cells in S/G2 / M at IndicatedPhenotype No. of LTHC-ICs* Percent Cells†
Time (h) After Isolation
Day 0 Total CD34/ 3,750 { 1,440
Cell Phenotype 0 24 48Day 7 Total CD34/ 3,481 { 617
CD34/ PKH2bright 1,092 { 764 3.1 { 2.3 G0CD34/ 1.45 { 0.52* 2.61 { 1.41† 12.73 { 3.38*
CD34/ PKH2dim 2,389 { 558 14.9 { 1.9 G0CD34/PKH2dim 2.55 { 0.87* 14.24 { 5.36† 11.31 { 2.37*
Simultaneous CD34/PKH2 cell sorting on day 7 was performed as Cultures were initiated with freshly isolated BM G0CD34/ cells and
illustrated in Fig 7B. Paired data from 4 BM samples are reported as G0CD34/PKH2dim cells at day 7 isolated from paired samples as illus-
the mean { SEM. trated in Fig 7. Both cultures were supported with 100 ng/mL each of
* Total number of LTHC-ICs normalized per 105 initial CD34/ cells. IL-3, IL-6, and SCF in complete medium. At initiation and at 24-hour
† Percent cells with indicated phenotype given relative to the total intervals, samples were assayed for cell-cycle analysis by the propid-
number of cells in culture on day 7. ium iodide method. Results are expressed as the mean { SEM, n 
3.
* P  .05, † P  .05: paired t-tests.
reentering G0 retained a significantly higher frequency of
LTHC-ICs (1.9 { 0.2) compared with cells reisolated in G1
cell-cycle activation of G0CD34/ cells isolated before andor S/G2 / M (0.8 { 0.25 and 0.3 { 0.2, respectively, P 
after ex vivo expansion was measured in short-term cul-
.05), indicating that reacquisition of minimal RNA content
tures. Suspension cultures from paired BM samples wereafter in vitro division was a distinct property of primitive
initiated with day 0 G0CD34/ cells and 1 week later withhematopoietic cells assayed as LTHC-ICs. However, the
day 7 G0CD34/PKH2dim cells reisolated with minimal RNALTHC-IC frequency of CD34/ cells reentering G0 after a
content after ex vivo expansion. Both cultures were stimu-7-day ex vivo expansion was significantly lower than that
lated with the IL-3-IL-6-SCF combination. Cells fromdetected among nonproliferating CD34/PKH2bright cells, har-
paired cultures were subjected to cell-cycle analysis at initi-vested from the same cultures (4.1 { 0.5, P  .05; Fig 8),
ation and at 24-hour intervals (Table 3). Day 7 G0CD34/adding further evidence that a prolonged quiescent state was
cells quickly progressed into active phases of the cell cycleassociated with primitive hematopoietic function.10
(14.24% of cells in S/G2 / M at 24 hours) compared withThe apparent difference in the LTHC-IC content of
freshly isolated G0CD34/ cells (2.61% of cells in S/G2 /freshly isolated G0CD34/ cells (6.5%{ 2.0%, Fig 3) versus
M, P .05), indicating that after in vitro division under ourcultured CD34/ cells reisolated with minimal RNA content
culture conditions, G0CD34/ cells not only had a reduced(1.9% { 0.2%; Fig 8) prompted us to compare the relative
frequency of LTHC-ICs but were unable to reacquire theirlevel of cell-cycle dormancy of these two groups of cells
initial degree of cell-cycle dormancy.to investigate the relationship between cell-cycle quies-
cence and primitive hematopoietic function. The rate of
DISCUSSION
In this study, we used simultaneous DNA/RNA staining
and flow cytometric cell sorting to isolate and characterize
fresh CD34/ cells in different subcompartments of the G0/
G1 phase of the cell cycle, and to examine the relationship
between reacquisition of mitotic quiescence and mainte-
nance of primitive hematopoietic potential among proliferat-
ing ex vivo–expanded CD34/ cells. Conventional cell-cycle
analysis based on measurement of DNA content can classify
cells in G0/G1 or S/G2 / M phases of the cell cycle as
noncycling and cycling cell populations, respectively.15,32
This kind of static measurement categorizes all cells con-
taining 2n DNA as G0/G1, and as such fails to address the
kinetics of cell-cycle progression or heterogeneity of the
cell-cycle rate within a given cell population. In addition,
since the vast majority of primitive HPCs isolated in steady-
state hematopoiesis reside in the G0/G1 phase,1 the simple
distinction between S/G2 / M and G0/G1 cells is of limited
interest. Data obtained with simultaneous DNA/RNA stain-Fig 8. LTHC-IC frequencies of ex vivo–expanded CD34" cells iso-
ing allow for further fractionation of G0/G1 cells and canlated in different phases of the cell cycle. CD34" cell subsets were
sorted as described in Fig 7. LTHC-IC frequencies are given per 100 provide additional insight into the cell-cycle kinetics of he-
cells of each phenotype indicated. Paired data from four BM samples matopoietic cells. Our studies demonstrate that CD34/ cells
are reported as the mean Ô SEM. Statistical analysis was made by
within the G0/G1 phase of the cell cycle can be separated intoANOVA followed by SNK pairwise comparisons. *P Ú .05 v G0, G1, distinct subpopulations based on RNA content. In kineticand S/G2 " M CD34" PKH2dim cells; **P Ú .05 v G1 and S/G2 " M
CD34"PKH2dim cells. experiments reported here (Fig 2), we demonstrate the ability
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of our staining procedure to discern between mitotically dor- comparing the level of quiescence of freshly isolated
G0CD34/ cells with that of G0CD34/ cells recovered aftermant cells (G0CD34/ cells) and those in which cell-cycle
activation had already been triggered (G1CD34/ cells). cell division in ex vivo expansion cultures, our data showed
that CD34/ cells reentering G0 have a shorter prereplicatingDiscrimination between G0 and G1 phases is a controver-
sial subject. Our definition of G0 cells as those displaying phase than freshly isolated G0CD34/ cells. These findings
suggest that under our ex vivo culture conditions, once HPCsminimal PY staining may appear arbitrary. In fact, we made
no attempt to determine absolute counts of CD34/ cells in have started to proliferate in vitro, they can no longer return
to the same initial dormancy state, possibly as a result of athe G0 phase, but rather assayed the functional properties of
cell subsets isolated relative to one another using combined progressive loss of developmental capacity. Indeed, our
group has recently demonstrated a correlation between cellDNA/RNA staining. While expression of other markers such
as Ki-6728 or D-type cyclins34 may be more absolute criteria division and loss of primitive hematopoietic function.27 To-
gether, these observations may be interpreted to suggest thatfor G0/G1 discrimination, staining for these markers requires
cell permeabilization and therefore prevents functional char- primitive cells reenter a state of transient quiescence after
in vitro division, thereby allowing their reisolation in G0,acterization of cells isolated in separate cell-cycle subcom-
partments. Since the studies of Darzynkiewicz and Tra- while less primitive HPCs may bypass the G0 phase and
return immediately to a prereplicating stage. These resultsganos,24 total RNA measurements have been used to describe
the progression of cells from a resting state, ie, G0, to an lend support to a hypothesis proposed by Ogawa8 that ‘‘the
self-renewal process is associated with renewed dormancyactive prereplicating state, G1. In addition, the appearance
of cell-cycle stage-specific markers such as Ki-67 or D- in the cell cycle, while the differentiation process is charac-
terized by continuous cell doubling.’’type cyclins requires RNA synthesis, an event that may be
detectable with DNA/RNA staining before the actual appear- The initial cell-cycle position before ex vivo expansion
of LTHC-ICs reselected in G0 after in vitro proliferation wasance of these moieties.
In steady-state BM CD34/ cells, the relationship between not directly determined in the present study. Our data (Figs
3 and 5B) show that the majority of LTHC-ICs originateposition within the G0/G1 phase and primitive hematopoietic
function is striking. Whereas late committed progenitors be- in G0. However, a significant proportion of these primitive
progenitor cells arise from early G1. Therefore, the possibil-longed to immediate prereplicating phases, CD34/ cells iso-
lated in G0 or early G1 were enriched for multipotential CFUs ity exists that a cycling G1 LTHC-IC would reenter G0 after
expansion culture. However, the higher generation of CD34/and for LTHC-ICs. These observations support the concept
that in steady-state hematopoiesis, the turnover of BM primi- cells (Table 1) and CFUs (Fig 6) in identical expansion
cultures by G0 LTHC-ICs suggests that secondary LTHC-tive hematopoietic cells is low compared with that of more
committed progenitors, and that a direct relationship exists ICs detected in the PKH2dim fraction belong initially to the
G0 fraction.between the rate of cycling and the degree of lineage com-
mitment. These observations are in line with a recent report35 The findings in this communication shed new light on
previous data reported by our laboratory. We previouslyshowing a correlation between the proportion of cells in S/
G2 / M and the proportion of committed progenitors in demonstrated in both the human10,27 and the murine11 systems
that the primitive hematopoietic potential of primitive HPCsmurine BM.
The same method of cell-cycle fractionation was less ef- undergoing proliferation in vitro was inferior to that of cells
remaining quiescent in expansion cultures, referred to asfective in separating primitive LTHC-ICs when applied to
MPB CD34/ cells, thus confirming previous reports demon- CNR cells. The present results indicate that although the
strating the cell-cycle status homogeneity of MPB CD34/ frequency of LTHC-ICs among proliferating cells was lower
than that of CNR cells, the residual primitive hematopoieticcells, ie, the small percentage of cells in G281 and the absence
of cells in S/G2 / M,18,32,33 compared with BM CD34/ cells. activity of in vitro proliferating cells could be mostly attrib-
uted to a specific identifiable subgroup of these cells, namelyThe comparison of correlated LTHC-IC activity and cell-
cycle status in BM and MPB reported here (Fig 3) extends that composed of cells that had reentered into a relative
quiescent state. It remains to be established whether differentthese findings and suggests that a subgroup of BM CD34/
cells residing in late G1 phase and whose primitive hemato- culture conditions such as coculture with stromal layers or
addition of cytokines such as Flt3 ligand36-38 or thrombopoie-poietic function is largely compromised are not recovered
in the MPB of G-CSF–treated donors. tin,39,40 which have been shown to affect activation and main-
tenance of primitive cells, would modify the distribution ofThe application of membrane dye cell tracking coupled
with DNA/RNA fractionation allowed us to examine for the LTHC-ICs among the different fractions isolated after ex
vivo expansion as described here.first time whether primitive hematopoietic cells (LTHC-ICs)
proliferating in vitro are capable of reentering into a G0 state. When viewed together, our results can be used to propose
a model of the cell cycle of hematopoietic cells similar toA relationship between cycling status and hematopoietic
function similar to that observed among freshly isolated that proposed by Gerdes et al31 for PHA-stimulated periph-
eral blood lymphocytes. In this model (Fig 9), primitiveCD34/ cells was demonstrated for ex vivo–expanded
CD34/ cells belonging to different phases of the cell cycle. LTHC-ICs, initially residing in G0 in the BM microenviron-
ment, can enter the cell cycle via start sequences leading toIndeed, CD34/ cells reisolated with minimal RNA content
(G0) were enriched for LTHC-IC activity compared with G1. In the event of a self-renewal cycle, cells may reenter
into the initial low RNA dormancy state after mitosis,CD34/ cells reisolated in G1 or S/G2 / M. However, when
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